UTI Statistics
Total Valuation
UTI has a market cap or net worth of $891.66 million. The enterprise value is $1.09 billion.
| Market Cap | 891.66M |
| Enterprise Value | 1.09B |
Important Dates
The next confirmed earnings date is Wednesday, November 20, 2024, after market close.
| Earnings Date | Nov 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
UTI has 53.81 million shares outstanding. The number of shares has increased by 32.22% in one year.
| Shares Outstanding | 53.81M |
| Shares Change (YoY) | +32.22% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 2.57% |
| Owned by Institutions (%) | 67.38% |
| Float | 43.10M |
Valuation Ratios
The trailing PE ratio is 33.36 and the forward PE ratio is 18.70. UTI's PEG ratio is 1.25.
| PE Ratio | 33.36 |
| Forward PE | 18.70 |
| PS Ratio | 1.04 |
| Forward PS | 1.13 |
| PB Ratio | 3.72 |
| P/FCF Ratio | 18.72 |
| PEG Ratio | 1.25 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.75, with an EV/FCF ratio of 22.84.
| EV / Earnings | 48.14 |
| EV / Sales | 1.54 |
| EV / EBITDA | 14.75 |
| EV / EBIT | 23.84 |
| EV / FCF | 22.84 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.31.
| Current Ratio | 1.02 |
| Quick Ratio | 0.84 |
| Debt / Equity | 1.31 |
| Debt / EBITDA | 2.48 |
| Debt / FCF | 6.57 |
| Interest Coverage | 4.64 |
Financial Efficiency
Return on equity (ROE) is 13.00% and return on invested capital (ROIC) is 5.06%.
| Return on Equity (ROE) | 13.00% |
| Return on Assets (ROA) | 4.04% |
| Return on Capital (ROIC) | 5.06% |
| Revenue Per Employee | $235,542 |
| Profits Per Employee | $7,535 |
| Employee Count | 3,000 |
| Asset Turnover | 1.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $10.24 million in taxes.
| Income Tax | 10.24M |
| Effective Tax Rate | 25.53% |
Stock Price Statistics
The stock price has increased by +82.49% in the last 52 weeks. The beta is 1.35, so UTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | +82.49% |
| 50-Day Moving Average | 16.37 |
| 200-Day Moving Average | 15.80 |
| Relative Strength Index (RSI) | 53.10 |
| Average Volume (20 Days) | 267,298 |
Short Selling Information
The latest short interest is 1.94 million, so 3.60% of the outstanding shares have been sold short.
| Short Interest | 1.94M |
| Short Previous Month | 1.78M |
| Short % of Shares Out | 3.60% |
| Short % of Float | 4.50% |
| Short Ratio (days to cover) | 5.26 |
Income Statement
In the last 12 months, UTI had revenue of $706.63 million and earned $22.61 million in profits. Earnings per share was $0.50.
| Revenue | 706.63M |
| Gross Profit | 381.22M |
| Operating Income | 45.65M |
| Pretax Income | 40.10M |
| Net Income | 22.61M |
| EBITDA | 73.78M |
| EBIT | 45.65M |
| Earnings Per Share (EPS) | $0.50 |
Balance Sheet
The company has $116.33 million in cash and $312.87 million in debt, giving a net cash position of -$196.54 million or -$3.65 per share.
| Cash & Cash Equivalents | 116.33M |
| Total Debt | 312.87M |
| Net Cash | -196.54M |
| Net Cash Per Share | -$3.65 |
| Equity (Book Value) | 239.38M |
| Book Value Per Share | 4.45 |
| Working Capital | 2.80M |
Cash Flow
In the last 12 months, operating cash flow was $72.24 million and capital expenditures -$24.61 million, giving a free cash flow of $47.64 million.
| Operating Cash Flow | 72.24M |
| Capital Expenditures | -24.61M |
| Free Cash Flow | 47.64M |
| FCF Per Share | $0.89 |
Margins
Gross margin is 53.95%, with operating and profit margins of 6.46% and 4.23%.
| Gross Margin | 53.95% |
| Operating Margin | 6.46% |
| Pretax Margin | 5.68% |
| Profit Margin | 4.23% |
| EBITDA Margin | 10.44% |
| EBIT Margin | 6.46% |
| FCF Margin | 6.74% |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.22% |
| Shareholder Yield | -32.22% |
| Earnings Yield | 2.54% |
| FCF Yield | 5.34% |
Analyst Forecast
The average price target for UTI is $21.60, which is 30.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.60 |
| Price Target Difference | 30.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 1.97 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.97 |
| Piotroski F-Score | 6 |